Gapping up
In reaction to strong earnings/guidance:
- N/A.
M&A news:
- NRE +2.1% (to be acquired by AXA Investment Managers - Real Assets for approximately $17.03/share)
Select EU financial related names showing strength:
- BCS +0.8%, BBVA +0.7%, CS +0.6%, SAN +0.5%, DB +0.5%
Other news:
- KPTI +8.5% (expects XPOVIO to become commercially available in the U.S. on or before July 10)
- AZUL +2.1% (reports preliminary traffic results for June)
- TEVA +1.6% (continued strength)
- ALXN +1% (announces European Commission marketing authorization approval of ULTOMIRIS for adults with paroxysmal nocturnal hemoglobinuria)
Analyst comments:
- N/A